FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used for diagnosing inflammation in epicardial adipose tissue in patients with ischemic heart disease and coronary atherosclerosis. That is ensured by analyzing the patient's blood serum with the concentration of the N-terminal region of the medulla natriuretic propeptide. If its value is 19 fmole/ml and more, inflammation in epicardial adipose tissue is diagnosed.
EFFECT: invention enables diagnosing an inflammation in epicardial adipose tissue and predicting a cardiovascular risk in patients with ischemic heart disease and coronary atherosclerosis.
1 cl, 2 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR NON-INVASIVE DETERMINATION OF PRODUCTION LEVELS OF REACTIVE OXYGEN FORMS BY ADIPOCYTES OF EPICARDIAL ADIPOSE TISSUE IN PATIENTS WITH CORONARY HEART DISEASE AND CORONARY ATHEROSCLEROSIS | 2022 |
|
RU2789592C1 |
| METHOD OF NONINVASIVE DIAGNOSTICS OF ADIPOCYTE HYPERTROPHY OF EPICARDIAL ADIPOSE TISSUE OF PATIENTS WITH ISCHEMIC HEART DISEASE AND CORONARY ATHEROSCLEROSIS | 2020 |
|
RU2743837C1 |
| METHOD FOR VISCERAL OBESITY DETERMINATION BASED ON MAGNETIC RESONANCE TOMOGRAPHY OF HEART | 2018 |
|
RU2721542C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE DECOMPENSATION OF ISCHEMIC CHRONIC HEART FAILURE WITH SYSTOLIC DYSFUNCTION OF THE LEFT VENTRICLE OF THE HEART AFTER COMPLETE MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770271C1 |
| METHOD FOR PREDICTING RISKS OF PROGRESSION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH NON-OBSTRUCTIVE ATHEROSCLEROSIS OF CORONARY ARTERIES DURING 12 MONTHS OF OBSERVATION | 2023 |
|
RU2804705C1 |
| METHOD FOR PREDICTING CARDIOVASCULAR COMPLICATIONS WITHIN 12 MONTHS AFTER ELECTIVE ENDOVASCULAR MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2020 |
|
RU2749485C1 |
| METHOD FOR PREDICTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE COMBINED WITH ISCHEMIC MITRAL INSUFFICIENCY | 2019 |
|
RU2712634C1 |
| METHOD FOR PREDICTION OF RISK OF CARDIOVASCULAR MORTALITY IN PATIENTS SUFFERING FROM CHRONIC ISCHEMIC HEART FAILURE COMBINED WITH TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2531947C1 |
| METHOD FOR PREDICTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE IN A COMBINATION WITH POSTINFARCTION LEFT VENTRICULAR ANEURYSM | 2019 |
|
RU2712629C1 |
| METHOD FOR PREDICTING ADVERSE OUTCOMES UP TO 12 MONTHS IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2020 |
|
RU2747693C1 |
